BusinessOHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies MeetingBy Nasdaq OMXMay 8, 2017, 12:03 PM UTC
BusinessActinium Pharmaceuticals Announces Sponsorship of the Acute Leukemia Forum 2017By Nasdaq OMXApr 18, 2017, 11:00 AM UTC
BusinessActinium Pharmaceuticals Appoints Pharmaceutical Industry Executive Ajit S. Shetty, Ph.D., to the Company’s Board of DirectorsBy Nasdaq OMXMar 28, 2017, 11:02 AM UTC
BusinessActinium Pharmaceuticals Appoints Pharmaceutical Industry Executive Ajit S. Shetty, Ph.D., to the Company’s Board of DirectorsBy Nasdaq OMXMar 28, 2017, 11:02 AM UTC
BusinessActinium Announces Receipt of Positive Scientific Advice from the European Medicines Agency for Iomab-BBy Nasdaq OMXMar 21, 2017, 11:02 AM UTC
BusinessActinium Announces Receipt of Positive Scientific Advice from the European Medicines Agency for Iomab-BBy Nasdaq OMXMar 21, 2017, 11:02 AM UTC
BusinessActinium Announces Receipt of Positive Scientific Advice from the European Medicines Agency for Iomab-BBy Nasdaq OMXMar 21, 2017, 11:02 AM UTC
BusinessActinium Pharmaceuticals to Sponsor 4th Annual Summit on Hematologic MalignanciesBy Nasdaq OMXMar 16, 2017, 9:30 PM UTC
